Gravina, G., Marampon, F., Petini, F., Biordi, L., Sherris, D., Jannini, E., et al. (2011). The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells. ENDOCRINE-RELATED CANCER, 18, 385-400 [10.1530/ERC-11-0045].
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells.
JANNINI, EMMANUELE ANGELO FRANCESCO;
2011-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
